Ligand validation:5VS3

PPV: PYROPHOSPHATE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5VS3_PPV_P_106	94%	49%	0.082	0.983	0.76	1.2	-	1	0	0	100%	0.8
4KLO_PPV_A_405	95%	44%	0.069	0.975	0.86	1.3	-	2	0	0	100%	1
7RBI_PPV_A_402	95%	64%	0.078	0.983	0.52	0.86	-	-	0	0	100%	0.3
4RQ4_PPV_A_412	95%	46%	0.079	0.983	0.7	1.38	-	2	0	0	100%	0.3
4RQ5_PPV_A_409	95%	42%	0.082	0.985	0.55	1.68	-	3	0	0	100%	0.7
4UAZ_PPV_A_404	94%	60%	0.082	0.983	0.7	0.81	-	-	0	0	100%	0.6
3JYY_PPV_A_738	100%	57%	0.037	0.99	0.72	0.94	-	-	0	0	100%	1
5FLL_PPV_B_701	100%	49%	0.045	0.989	0.7	1.26	-	1	0	0	100%	1
8YLA_PPV_B_404	100%	53%	0.052	0.996	0.7	1.09	-	1	0	0	100%	1
4OKM_PPV_B_904	99%	49%	0.055	0.989	0.7	1.27	-	2	0	0	100%	1
6FCD_PPV_A_406	99%	42%	0.058	0.992	1.38	0.9	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.